Gastric Balloons Market Size and Share - Growth Analysis Report and Forecast Trends 2026-2030

Gastric balloons are soft, silicone or flexible devices placed in the stomach via endoscopic procedure to reduce hunger and promote weight loss, typically remaining in place for six to twelve months before removal. The market encompasses single-balloon and dual-balloon systems, with saline-filled designs representing the dominant product category in current clinical practice. The significant market valuation reflects growing adoption across bariatric clinics, hospitals, and ambulatory surgical centers worldwide as minimally invasive weight-loss options gain mainstream acceptance.

• •Single-balloon systems hold the largest product segment share due to simpler placement procedures and lower complication rates
• •Endoscopic insertion remains the primary administration method, while saline-filled balloons dominate by filling material type
• •Hospitals represent the primary end-user segment, though specialized bariatric clinics are expanding rapidly

Rising global obesity rates, now affecting over 650 million adults worldwide, are the primary driver of demand for weight-management interventions beyond diet and exercise. Patients and physicians increasingly favor minimally invasive options that avoid the risks and recovery time associated with bariatric surgery, positioning gastric balloons as an attractive intermediate solution. Government initiatives targeting obesity reduction and expanding insurance coverage for endoscopic weight-loss procedures are further accelerating market adoption in developed markets.

• •Growing preference for non-invasive and minimally invasive weight-loss procedures over surgical options
• •Advancements in endoscopic technologies improving placement accuracy and patient comfort
• •Expanding clinical evidence supporting long-term weight loss outcomes driving physician adoption

The market is segmented by product type into single-balloon, dual-balloon, and multi-balloon systems, with single-balloon devices maintaining the largest share due to established clinical track records and ease of use. By filling material, saline-filled balloons dominate the market, though gas-filled alternatives offer distinct positioning advantages in specific patient populations. North America accounts for the largest regional share at over 40%, driven by higher obesity prevalence, established healthcare infrastructure, and broader reimbursement coverage, while Asia-Pacific emerges as the fastest-growing region due to rising obesity rates in developing economies.

• •North America held the dominant regional share in 2025, supported by advanced healthcare infrastructure and higher obesity prevalence
• •Single-balloon systems and saline-filled options maintain dominant market shares across all regions
• •Bariatric clinics and hospitals represent the primary end-user segments, with ambulatory centers gaining share

What are the recent trends and outlook?

The market is moving toward procedureless and swallowable balloon systems that reduce reliance on endoscopic facilities and trained specialists, potentially expanding access to a broader patient population. Digital integration, including connected balloon systems with mobile health applications for patient monitoring and behavioral support, represents an emerging innovation frontier. With the market projected to continue expanding rapidly, increased clinical research, regulatory clearances in new geographies, and expanded reimbursement pathways are expected to drive sustained growth through the decade.

• •Procedureless balloon innovations are gaining traction, eliminating the need for endoscopy in placement and removal
• •Digital health integration and connected devices are enhancing patient adherence and clinical outcomes tracking
• •Expansion of specialized weight-loss clinics and increasing obesity awareness campaigns are broadening the addressable market